Download this slideset from a live CCO symposium for an expert overview on applying pediatric ALL regimens to the treatment of AYA and adult patients with ALL.
Download this slideset from a live CCO symposium for an expert overview of considerations regarding the use of asparaginase in the treatment of ALL, including discussion of available formulations and optimal management of hypersensitivity reactions.
Download this slideset from a live CCO symposium for an expert overview on identifying and managing adverse events associated with asparaginase-based therapy in patients with ALL, including discussion of hepatotoxicity, thrombosis, pancreatitis, hypertriglyceridemia, and factors contributing to their development.
Download this short summary slideset of key takeaways from a live CCO Webinar on the optimal use of pediatric asparaginase-based regimens in the treatment of a AYA and adult patients with ALL.
Watch this on-demand webcast of a live CCO webinar where an expert panel discusses the optimal use of pediatric asparaginase regimens in the treatment of AYA and adult patients with ALL, including patient case discussions and practical guidance on strategies to support completion of therapy.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.